Shield Therapeutics Aims for Financial Boost through Share Subscription

Shield Therapeutics (GB:STX) has released an update.

Shield Therapeutics is set to raise $10 million through a share subscription agreement with AOP Health, contingent on shareholder approval, which would grant AOP a controlling stake. Additionally, the company plans a RetailBook Offer to raise up to £1 million from existing retail shareholders. This financial maneuver is crucial for Shield’s goal of becoming cash flow positive by the end of 2025.

For further insights into GB:STX stock, check out TipRanks’ Stock Analysis page.